Service by

Home Journal Issues Instructions for Authors Editorial Board About Journal Aims & Scope


Original Research Open Access
RMJ. 2013; 38(2): 125-126


Comparison between 25% Benzyl Benzoate, 5% permethrin and 10% Crotamiton in the treatment of scabies in Gaza

Basel Taher Alrawashdeh, Kaled Alazab.

Abstract
Objective: to compare the efficacy of three different modalities treatments for scabies.
Methods: a prospective study was carried out at Dermatology clinic at Jordanian military field hospital in Gaza from August 2012 to October 2012.A total number of one hundred and twenty patients were included in this study. Scabies was diagnosed by clinical examination with three of the following criteria: 1.burrows identification, (2) presence of excoriated papules at the classical sites, (3) nocturnal itching and (4) positive family history and was confirmed by direct light microscopic examination. Patients were divided into three equal groups 40 patients in each: The first group received 5% Permethrin cream, the second group received 25% Benzyl Benzoate and the third group received 10%Crotamiton lotion. To assess cure rate we followed these patients up to one and two weeks after completing their treatment. Absence of itching along with no new lesions appearing and disappearing of the old lesions was considered a cure.
Result: The group who received 5% Permethrin cream showed the highest cure rate, while those who received 10% Crotamiton lotion showed the lowest cure rate.
Conclusion: 5 % Permethrin cream rinse was the best treatment for scabies

Key words: Permethrin, crotamiton, scabies, benzyl benzoate


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Basel Taher Alrawashdeh
Articles by Kaled Alazab
on Google
on Google Scholar
Article Statistics
 Viewed: 3247
Downloaded: 473
Cited: 0


REFERENCES
1. Feldmeier H, Jackson A, Ariza L, et al. The epidemiology of scabies in an impoverished community in rural Brazil: Presence and severity of disease are associated with poor living conditions and illiteracy. J Am Acad Dermatol.2009; 60:436-43. [DOI via Crossref]    [Pubmed]   
2. Hengge UR, Currie BJ, Jager G, et al. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis. 2006; 6:769-79. [DOI via Crossref]   
3. Hegazy AA, Darwish NM, Abdel-Hamid IA, et al. Epidemiology and control of scabies in an Egyptian village. Int J Dermatol. 1999; 38:291-5..
4. Jacobson, CC, and. Abel EA. Parasitic infestations .J Am Acad Dermatol. 2007; 56:1026-43. [DOI via Crossref]    [Pubmed]   
5. Usha V and Nair TV. A comparative study of oral Ivermectin and topical Permethrin cream in the treatment of scabies. J Am Acad Dermatol. 2000; 42:236-40. [DOI via Crossref]   
6. Al-Rawashdeh B, Al-Momani T, Al-Hmoud N, Helalat M and Bderat J.. Patterns of Skin Diseases at the Jordanian Hospital in Gaza. JRMS. March 2012; 19(1): 78-81.
7. Rasmussen JE. Antiparasitic agents. Comprehensive dermatologic drug therapy; 2001. p. 537-46.
8. Christine CJ and Elizabeth AA. Parasitic infestations. J Am Acad Dermatol. 2007; 56:1026043.
9. Victoria J, Trujillo R. Topical Ivermectin: a new successful treatment for scabies. Pediatr Dermatol. 2001; 18:63-5. [DOI via Crossref]   
10. Cook AM, Romanelli F. Ivermectin for the treatment of resistant Scabies. Ann Pharmacotherapy. 2003; 37:279-81. [DOI via Crossref]   
11. Marty P, Gari-Toussaint M, Le Fichoux Y, et al. Efficacy of Ivermectin in the treatment of an epidemic of sarcoptic scabies.Ann Trop Med Parasitol. 1994; 88:453.
12. Kar SK, Mania J, Patnaik S. The use of Ivermectin in scabies. Med J India .1994; 7:15-6.

How to Cite this Article
Pubmed Style

Alrawashdeh BT, Alazab K. Comparison between 25% Benzyl Benzoate, 5% permethrin and 10% Crotamiton in the treatment of scabies in Gaza. RMJ. 2013; 38(2): 125-126.



Web Style

Alrawashdeh BT, Alazab K. Comparison between 25% Benzyl Benzoate, 5% permethrin and 10% Crotamiton in the treatment of scabies in Gaza. www.scopemed.org/?mno=31273 [Access: October 20, 2017].



AMA (American Medical Association) Style

Alrawashdeh BT, Alazab K. Comparison between 25% Benzyl Benzoate, 5% permethrin and 10% Crotamiton in the treatment of scabies in Gaza. RMJ. 2013; 38(2): 125-126.



Vancouver/ICMJE Style

Alrawashdeh BT, Alazab K. Comparison between 25% Benzyl Benzoate, 5% permethrin and 10% Crotamiton in the treatment of scabies in Gaza. RMJ. (2013), [cited October 20, 2017]; 38(2): 125-126.



Harvard Style

Alrawashdeh, B. T. & Alazab, K. (2013) Comparison between 25% Benzyl Benzoate, 5% permethrin and 10% Crotamiton in the treatment of scabies in Gaza. RMJ, 38 (2), 125-126.



Turabian Style

Alrawashdeh, Basel Taher, and Kaled Alazab. 2013. Comparison between 25% Benzyl Benzoate, 5% permethrin and 10% Crotamiton in the treatment of scabies in Gaza. Rawal Medical Journal, 38 (2), 125-126.



Chicago Style

Alrawashdeh, Basel Taher, and Kaled Alazab. "Comparison between 25% Benzyl Benzoate, 5% permethrin and 10% Crotamiton in the treatment of scabies in Gaza." Rawal Medical Journal 38 (2013), 125-126.



MLA (The Modern Language Association) Style

Alrawashdeh, Basel Taher, and Kaled Alazab. "Comparison between 25% Benzyl Benzoate, 5% permethrin and 10% Crotamiton in the treatment of scabies in Gaza." Rawal Medical Journal 38.2 (2013), 125-126. Print.



APA (American Psychological Association) Style

Alrawashdeh, B. T. & Alazab, K. (2013) Comparison between 25% Benzyl Benzoate, 5% permethrin and 10% Crotamiton in the treatment of scabies in Gaza. Rawal Medical Journal, 38 (2), 125-126.




Instructions for Authors

AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

WHO Index Medicus IMEMR,
Emromedex,
Pakmedinet,
ExtraMED and
Scopus

Approved by the Higher Education Commission of Pakistan and Pakistan Medical and Dental Council



The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.